GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 135 filers reported holding GOSSAMER BIO INC in Q4 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $30,366 | -41.9% | 24,100 | 0.0% | 0.00% | – |
| Q4 2022 | $52,297 | -81.9% | 24,100 | 0.0% | 0.00% | – |
| Q3 2022 | $288,718 | +42.9% | 24,100 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $202,000 | -3.3% | 24,100 | 0.0% | 0.00% | – |
| Q1 2022 | $209,000 | -23.4% | 24,100 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $273,000 | -6.8% | 24,100 | +3.3% | 0.00% | 0.0% |
| Q3 2021 | $293,000 | +55.0% | 23,327 | 0.0% | 0.00% | – |
| Q2 2021 | $189,000 | -86.0% | 23,327 | -84.0% | 0.00% | -100.0% |
| Q1 2021 | $1,347,000 | -14.6% | 145,607 | -10.7% | 0.00% | 0.0% |
| Q4 2020 | $1,577,000 | +630.1% | 163,104 | +837.6% | 0.00% | – |
| Q3 2020 | $216,000 | -4.4% | 17,395 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $226,000 | +1.3% | 17,395 | -20.8% | 0.00% | 0.0% |
| Q1 2020 | $223,000 | -31.6% | 21,963 | +5.4% | 0.00% | 0.0% |
| Q4 2019 | $326,000 | +23.5% | 20,839 | +32.3% | 0.00% | 0.0% |
| Q3 2019 | $264,000 | – | 15,752 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,370,000 | $4,044,000 | 0.97% |
| Octagon Capital Advisors LP | 3,958,069 | $4,749,683 | 0.66% |
| Palo Alto Investors LP | 3,465,152 | $4,158,182 | 0.34% |
| NEA Management Company, LLC | 3,467,406 | $4,160,887 | 0.32% |
| APIS CAPITAL ADVISORS, LLC | 180,000 | $216,000 | 0.22% |
| Boxer Capital, LLC | 3,336,928 | $4,004 | 0.19% |
| HHLR ADVISORS, LTD. | 4,974,041 | $5,968,849 | 0.13% |
| Artal Group S.A. | 3,028,171 | $3,634 | 0.11% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,363,170 | $2,835,804 | 0.10% |
| Birchview Capital, LP | 99,088 | $118,906 | 0.09% |